COVID-19 — Endothelial Axis and Coronary Artery Bypass Graft Patency: a Target for Therapeutic Intervention?

Gokce Topal^I; Andrzej Loesch^II; Michael R. Dashwood^III

DOI: 10.21470/1678-9741-2020-0303

• Article
• About the authors
• Statistics
• Comments
• Related content

^IDepartment of Pharmacology, Faculty of Pharmacy, Istanbul University, Istanbul, Turkey.
^IICentre for Rheumatology, Royal Free Hospital Campus, University College Medical School, London, United Kingdom.
^IIIDepartment of Surgical and Interventional Sciences, Royal Free Hospital Campus, University College Medical School, London, United Kingdom.

Correspondence
Gokce Topal https://orcid.org/0000-0001-7196-3179 Department of Pharmacology, Istanbul University, Faculty of Pharmacy 34116 Beyazit, Istanbul, Turkey E-mail: gtopal@istanbul.edu.tr